Professor Myles LewisProfessor of Precision Medicine & RheumatologyCentre: Experimental Medicine and RheumatologyEmail: myles.lewis@qmul.ac.ukTelephone: +44(0) 20 7882 3305ProfileResearchPublicationsSponsorsCollaboratorsDisclosuresProfileORCID iD: 0000-0001-9365-5345 Myles Lewis studied preclinical medicine at Cambridge University, and clinical medicine at Oxford University. During his Rheumatology clinical training at multiple London teaching hospitals, he has worked extensively on Systemic Lupus Erythematosus (SLE) and other connective tissue diseases. He was awarded a Clinical Research Fellowship from the Wellcome Trust in 2005, for his PhD at the Hammersmith Hospital/Imperial College London, focused on understanding the causes of accelerated heart disease in SLE. In 2011 for his ongoing lab research on the role of ubiquitination in SLE and autoimmune disease, he was awarded a Clinician Scientist Fellowship by Arthritis Research UK. In 2015 he was awarded the Lancet Prize for Clinician Scientists at the Academy of Medical Sciences for his research on ubiquitination genes in SLE. Professor Lewis also heads up a bioinformatics/biostatistics group analysing and integrating multi-omic data across autoimmune rheumatic diseases (SLE, Sjogren’s syndrome and rheumatoid arthritis). He is a group leader within the biostatistics and bioinformatics analysis teams for several rheumatoid arthritis studies including the Pathobiology of Early Arthritis Cohort (PEAC), the R4RA biopsy-driven randomised clinical trial and the Stratification of Biologic Therapies for RA by Pathobiology study (STRAP). He is a member of the bioinformatic analysis team for several stratified medicine projects including MRC MATURA, MRC RA-MAP, IMID-Bio and the EU Innovative Medicines Initiative (IMI) programme 3TR. He is a Fellow of the Turing Institute and an Academic Fellow of the Digital Environment Research Institute at Queen Mary.ResearchGroup members Bioinformatics and biostatistics team: Cankut Çubuk, Katriona Goldmann, Giovanni Giorli, Elisabetta Sciacca, Anna Surace Research staff (wet lab): Ilaria Esposito, Sotiria Manou-Stathopoulou, Yoanna Kontra, Chiara Giacomassi, Susan Wang Former group members: Felice Rivellese, Daniele Mauro, Christopher Johns, Fabiola Bene, Lu Zou, Kevin Blighe, Sharmila Rana, Xiujuan Hou, Simon Vyse, Adrian Shields, Sebastian Boeltz Bioinformatics and machine learning in stratified medicineProfessor Lewis leads a bioinformatics and biostatistics team involved in analysing and integrating multi-omic data including bulk & single cell RNA-Sequencing (RNA-Seq), genotype & expression Quantitative Trait Loci (eQTL) analysis, immunoglobulin repertoire analysis, CyTOF and protein microarray. Our group has interests in machine learning to predict clinical response for personalised/ stratified medicine, data visualisation of big data and disseminating results through interactive data web portals. Our group developed a number of R/shiny apps (https://peac.hpc.qmul.ac.uk/) to allow exploration of RNA-sequencing data on synovial biopsies from the Pathobiology of Early Arthritis Cohort (PEAC). This website allows researchers to directly compare synovium and blood genes and gene modules in early rheumatoid arthritis and see how gene expression correlates with clinical measures of disease activity and response to therapy, thus enabling in-depth interrogation of the data. In the R4RA clinical trial, our analysis of RNA-Seq data from synovial biopsies from this cohort showed that patients with low levels of B cell signature genes were less likely to respond to the B cell depleting agent rituximab in comparison to the IL-6 receptor inhibitor tocilizumab. Ubiquitination in autoimmune diseaseMy lab research involves understanding the effects of ubiquitination pathways on the immune system, and their impact on autoimmune rheumatic diseases especially SLE (lupus), rheumatoid arthritis (RA) and other connective tissue disorders. My research focuses on trying to understand how genetic variation in ubiquitination genes influences B cell differentiation and autoantibody production through regulation of the master transcription factor of inflammation, NF-kB, thus increasing susceptibility to lupus and autoimmune disease. Our work has important translational medical implications, since we aim to determine whether particular ubiquitination genes represent novel targets for new therapies to treat lupus, RA and other autoimmune diseases. Software Software packages in R and python published by Professor Lewis’s team include: R packages available from CRAN Spectrum performs fast self-tuning spectral clustering using an adaptive density aware spectral kernel. volcano3D enables visualisation of 3-way analyses of gene expression and other high dimensional 3-class data using 3D volcano plots or polar plots. glmmSeq enables analysis of longitudinal RNA-Seq and other omics data using mixed effect models which can either be negative binomial generalised linear mixed effects models (GLMM) which are suitable for RNA-Seq data or Gaussian linear mixed effects models (LMM). Analyses are parallelised for speed. nestedcv implements nested k*l-fold cross-validation for lasso and elastic-net regularised linear models via the ‘glmnet’ package and many other machine learning models via the ‘caret’ package. locuszoomr generates publication-ready regional gene locus plots similar to those produced by the web interface LocusZoom, but running locally in R. Genetic or genomic data with gene annotation tracks are plotted via R base graphics, 'ggplot2' or 'plotly', allowing flexibility and easy customisation including laying out multiple locus plots on the same page. easylabel enables interactive labelling of scatter plots, volcano plots and Manhattan plots using a ‘shiny’ and ‘plotly’ interface. Users can hover over points to see where specific points are located and click points on/off to easily label them. Labels can be dragged around the plot to place them optimally. R packages in Bioconductor enhancedVolcano generates publication-ready volcano plots with enhanced colouring and labelling. M3C performs Monte Carlo reference-based consensus clustering of high dimensional omics data. R packages on GitHub DEGGs tests for differential gene-gene correlations across different groups of samples in count data from high-throughput sequencing assays, leveraging gene-gene interaction graph network information. Packages published in collaboration with other teams shinyExprPortal is a visualisation tool which enables deployment of configuration file-based 'shiny' apps with minimal programming for interactive exploration and analysis showcase of molecular expression data. MUSTANG – Multi Stain Graph Attention Multiple Instance Learning – a graph neural network pipeline for whole slide image (WSI) classification using multi-stain embeddings and self-attention graph pooling. bbmix models RNA-seq reads using a mixture of 3 beta-binomial distributions to generate posterior probabilities for genotyping bi-allelic single nucleotide polymorphisms. Publications Lewis MJ, Spiliopoulou A, Goldmann K, Pitzalis C, McKeigue P, Barnes MR. nestedcv: an R package for fast implementation of nested cross-validation with embedded feature selection designed for transcriptomics and high dimensional data. Bioinform Adv 2023; 3(1): vbad048. PMID: 37113250 Henkin R, Goldmann K, Lewis MJ, Barnes MR. shinyExprPortal: a configurable 'shiny' portal for sharing analysis of molecular expression data. Bioinformatics 2024; 40(4): btae172. PMID: 38552327 Gallagher-Syed A, Rossi L, Rivellese F, Pitzalis C, Lewis MJ, Barnes M, Slabaugh G. MUSTANG: Multi-stain self-attention Graph Multiple Instance Learning pipeline for histopathology Whole Slide Images. British Machine Vision Conference 2023. arXiv:2309.10650 Gallagher-Syed A, Khan A, Rivellese F, Pitzalis C, Lewis MJ, Slabaugh G, Barnes MR. Automated segmentation of rheumatoid arthritis immunohistochemistry stained synovial tissue. Front Med Tech 2023 arXiv:2309.07255 Vigorito E, Barton A, Pitzalis C, Lewis MJ, Wallace C. BBmix: a Bayesian Beta-Binomial mixture model for accurate genotyping from RNA-sequencing. Bioinformatics 2023; btad393. PMID: 37338536 Sciacca E, Alaimo S, Silluzio G, Ferro F, Latora V, Pitzalis C, Pulvirenti A, Lewis MJ. DEGGs: an R package with shiny app for the identification of differentially expressed gene-gene interactions in high-throughput sequencing data. Bioinformatics 2023; 39(4): btad192. PMID: 37084249 John CR, Watson D, Barnes M, Pitzalis C, Lewis MJ. Spectrum: Fast density-aware spectral clustering for single and multi-omic data. Bioinformatics 2020; 36(4): 1159-66. PMID: 31501851 John CR, Watson D, Russ R, Goldmann K, Ehrenstein M, Pitzalis C, Lewis MJ, Barnes M. M3C: Monte Carlo reference-based consensus clustering. Sci Rep 2020; 10(1): 1816. PMID: 32020004 Publications Hanlon MM, Smith CM, Canavan M et al. (2024). Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onset. nameOfConference DOI: 10.1126/sciadv.adj1252 QMRO: qmroHref Bangash MA, Cubuk C, Iseppon F et al. (2024). Analgesic targets identified in mouse sensory neuron somata and terminal pain translatomes. nameOfConference DOI: 10.1016/j.celrep.2024.114614 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99461 Zack SR, Alzoubi O, Satoeya N et al. (2024). Another Notch in the Belt of Rheumatoid Arthritis. nameOfConference DOI: 10.1002/art.42937 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99462 Iseppon F, Kanellopoulos AH, Tian N et al. (2024). Sodium channels Nav1.7, Nav1.8 and pain; two distinct mechanisms for Nav1.7 null analgesia. nameOfConference DOI: 10.1016/j.ynpai.2024.100168 QMRO: qmroHref Rolas L, Stein M, Barkaway A et al. (2024). Senescent endothelial cells promote pathogenic neutrophil trafficking in inflamed tissues. nameOfConference DOI: 10.1038/s44319-024-00182-x QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/98188 Çubuk C, Lau R, Cutillas P et al. (2024). Phosphoproteomic profiling of early rheumatoid arthritis synovium reveals active signalling pathways and differentiates inflammatory pathotypes. nameOfConference DOI: 10.1186/s13075-024-03351-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99465 Aldeyarbi H, George S, Marchan G et al. (2024). AB1122 MALE LUPUS CHARACTERISTICS FROM MULTI ETHNIC COHORT. Scientific Abstracts DOI: 10.1136/annrheumdis-2024-eular.47 QMRO: qmroHref Lau R, Cubuk C, Rajeeve V et al. (2024). OP0218 SYNOVIAL PHOSPHOPROTEOME ANALYSIS OF LATE-STAGE RHEUMATOID ARTHRITIS PATIENTS (R4RA TRIAL) IDENTIFIES SIGNALLING PATHWAYS ASSOCIATED WITH PATHOTYPE AND RESPONSE TO RITUXIMAB AND TOCILIZUMAB. Scientific Abstracts DOI: 10.1136/annrheumdis-2024-eular.617 QMRO: qmroHref Corsiero E, Caliste M, Jagemann L et al. (2024). Autoimmunity to stromal-derived autoantigens in rheumatoid ectopic germinal centers exacerbates arthritis and affects clinical response. nameOfConference DOI: 10.1172/jci169754 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/96472 Aldeyarbi H, George S, Marchan G et al. (2024). P154 Male lupus characteristics from multi-ethnic cohort. nameOfConference DOI: 10.1093/rheumatology/keae163.193 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100690 Bai Z, Bartelo N, Aslam M et al. (2024). Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis. nameOfConference DOI: 10.1126/scitranslmed.adk3506 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99463 Henkin R, Goldmann K, Lewis M et al. (2024). shinyExprPortal: a configurable ‘shiny’ portal for sharing analysis of molecular expression data. nameOfConference DOI: 10.1093/bioinformatics/btae172 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99464 Nerviani A, Boutet M-A, Ghirardi GM et al. (publicationYear). Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis. nameOfConference DOI: 10.1038/s41467-024-46564-6 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95783 Khan M, Huang S, Marchan G et al. (2024). O36 HPV vaccination and cervical screening in SLE patients. Oral Presentations DOI: 10.1136/lupus-2024-el.45 QMRO: qmroHref Aldeyarbi HM, George S, Marchan G et al. (2024). P33 Male lupus characteristics from multi ethnic cohort. Poster Presentations DOI: 10.1136/lupus-2024-el.87 QMRO: qmroHref Pontarini E, Sciacca E, Chowdhury F et al. (2024). Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS). nameOfConference DOI: 10.1002/art.42772 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93514 Weisenfeld D, Zhang F, Donlin L et al. (2024). Associations Between Rheumatoid Arthritis Clinical Factors and Synovial Cell Types and States. nameOfConference DOI: 10.1002/art.42726 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100592 Meyer A, Zack SR, Nijim W et al. (2024). Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis. nameOfConference DOI: 10.1038/s41423-023-01108-8 QMRO: qmroHref Kang JB, Shen AZ, Gurajala S et al. (2023). Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution. nameOfConference DOI: 10.1038/s41588-023-01586-6 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93617 Lewis MJ (2024). Predicting best treatment in rheumatoid arthritis. nameOfConference DOI: 10.1016/j.semarthrit.2023.152329 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93971 Goldmann K, Spiliopoulou A, Iakovliev A et al. (2024). Expression quantitative trait loci analysis in rheumatoid arthritis identifies tissue specific variants associated with severity and outcome. nameOfConference DOI: 10.1136/ard-2023-224540 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91722 Zhang F, Jonsson AH, Nathan A et al. (2023). Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. nameOfConference DOI: 10.1038/s41586-023-06708-y QMRO: qmroHref Rivellese F, Nerviani A, Giorli G et al. (2023). Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials. nameOfConference DOI: 10.1016/s2665-9913(23)00241-2 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91982 Zack SR, Meyer A, Zanotti B et al. (2024). Notch ligands are biomarkers of anti-TNF response in RA patients. nameOfConference DOI: 10.1007/s10456-023-09897-2 QMRO: qmroHref Wang SS, Lewis MJ, Pitzalis C (publicationYear). DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis. nameOfConference DOI: 10.3390/biomedicines11071987 QMRO: qmroHref Sumner EJ, McCluskey D, Mahil SK et al. (2023). P17 A signature of IL-36 activation in systemic lupus erythematosus skin. nameOfConference DOI: 10.1093/bjd/ljad174.038 QMRO: qmroHref Kugler M, Dellinger M, Kartnig F et al. (2023). Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis. nameOfConference DOI: 10.1136/ard-2022-223396 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99466 Vigorito E, Barton A, Pitzalis C et al. (2023). BBmix: a Bayesian beta-binomial mixture model for accurate genotyping from RNA-sequencing. nameOfConference DOI: 10.1093/bioinformatics/btad393 QMRO: qmroHref Esposito I, Kontra I, Giacomassi C et al. (publicationYear). Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma. nameOfConference DOI: 10.3389/fimmu.2023.1164941 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88872 Rivellese F, Currado D, Giorli G et al. (2023). AB0340 MULTI-DRUG RESISTANT RA IS ASSOCIATED WITH HIGHER BASELINE DISEASE ACTIVITY, MULTI-MORBIDITY, AND LOWER QUALITY OF LIFE: ANALYSES FROM THE R4RA BIOPSY-DRIVEN CLINICAL TRIAL. nameOfConference DOI: 10.1136/annrheumdis-2023-eular.750 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92604 Pontarini E, Lucchesi D, Goldmann K et al. (2023). POS0292 TRANSCRIPTOMIC PROFILING OF SJOGREN’S SALIVARY GLANDS IDENTIFIES FOLLICULAR AND EXTRA-FOLLICULAR GENE SIGNATURES ASSOCIATED WITH RHEUMATOID FACTOR SEROPOSITIVITY. nameOfConference DOI: 10.1136/annrheumdis-2023-eular.5849 QMRO: qmroHref Mancuso S, Giacomassi C, Truglia S et al. (2023). POS1425 ANTIB2GLYCOPROTEIN I ANTIBODIES CAN INDUCE NETOSIS. nameOfConference DOI: 10.1136/annrheumdis-2023-eular.5467 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92488 Townsend K, Cove-Smith A, Rajakariar R et al. (2023). P056 Analysis of antibody response to SARS-CoV-2 vaccination and natural infection in a tertiary centre cohort of lupus nephritis patients. nameOfConference DOI: 10.1093/rheumatology/kead104.097 QMRO: qmroHref Sciacca E, Alaimo S, Silluzio G et al. (2023). DEGGs: an R package with shiny app for the identification of differentially expressed gene–gene interactions in high-throughput sequencing data. nameOfConference DOI: 10.1093/bioinformatics/btad192 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88920 Lewis MJ, Spiliopoulou A, Goldmann K et al. (2023). nestedcv: an R package for fast implementation of nested cross-validation with embedded feature selection designed for transcriptomics and high-dimensional data. nameOfConference DOI: 10.1093/bioadv/vbad048 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86188 Mauro D, Manou-Stathopoulou S, Rivellese F et al. (2023). UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus. nameOfConference DOI: 10.1016/j.jaut.2023.103023 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85700 Meyer A, Sienes RE, Nijim W et al. (2023). Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells. nameOfConference DOI: 10.1136/ard-2022-223284 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85702 Lewis MJ, Pitzalis C (2023). Progress continues in prediction of the response to treatment of RA. nameOfConference DOI: 10.1038/s41584-022-00890-5 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85699 Shikh MEME, Sayed RE, Aly NAR et al. (publicationYear). Follicular dendritic cell differentiation is associated with distinct synovial pathotype signatures in rheumatoid arthritis. nameOfConference DOI: 10.3389/fmed.2022.1013660 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82586 Wang J, Conlon D, Rivellese F et al. (2022). Synovial Inflammatory Pathways Characterize Anti‐TNF–Responsive Rheumatoid Arthritis Patients. nameOfConference DOI: 10.1002/art.42295 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/80119 Schmidt M, Sondermann JR, Gomez-Varela D et al. (publicationYear). Transcriptomic and proteomic profiling of NaV1.8-expressing mouse nociceptors. nameOfConference DOI: 10.3389/fnmol.2022.1002842 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82458 Manou-Stathopoulou S, Lewis MJ (2021). Diversity of NF-κB signalling and inflammatory heterogeneity in Rheumatic Autoimmune Disease. nameOfConference DOI: 10.1016/j.smim.2022.101649 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85703 Humby F, Durez P, Buch MH et al. (publicationYear). Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients:the R4-RA RCT. nameOfConference DOI: 10.3310/gopl1729 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/83755 Sciacca E, Surace AEA, Alaimo S et al. (2022). Network analysis of synovial RNA sequencing identifies gene-gene interactions predictive of response in rheumatoid arthritis. nameOfConference DOI: 10.1186/s13075-022-02803-z QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78500 Cooles FAH, Tarn J, Lendrem DW et al. (2022). Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming. nameOfConference DOI: 10.1136/annrheumdis-2022-222370 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85701 Banda NK, Deane KD, Bemis EA et al. (2022). Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.. nameOfConference DOI: 10.4049/jimmunol.2101170 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78948 Surace A, Sciacca E, Goldmann K et al. (2022). OP0077 SYNOVIAL RNA-SEQ ANALYSIS OF THE R4RA TRIAL IDENTIFIES SIGNATURES OF TREATMENT RESISTANCE AND REFRACTORY STATE IN RHEUMATOID ARTHRITIS. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.4380 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92605 Rivellese F, Cubuk C, Surace A et al. (2022). OP0085 CELL LINEAGE-SPECIFIC TRANSCRIPT DECONVOLUTION OF SYNOVIAL BIOPSIES FROM THE R4RA TRIAL IDENTIFIES CELL POPULATIONS ASSOCIATED WITH RESPONSE TO RITUXIMAB AND TOCILIZUMAB. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.4794 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/89103 Goldmann K, Vigorito E, Wallace C et al. (2022). OP0109 EXPRESSION QUANTITATIVE TRAIT LOCI IN EARLY TREATMENT-NAÏVE RHEUMATOID ARTHRITIS. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.4452 QMRO: qmroHref Prediletto E, Cubuk C, Pontarini E et al. (2022). POS0138 RHEUMATOID SYNOVIAL FIBROBLASTS DISPLAY IMPRINTED MEMORY OF THEIR SYNOVIAL ENDOTYPE WHICH CAN BE PLASTICALLY MODULATED BY B-CELLS CROSSTALK. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.2758 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92599 Pontarini E, Chowdhury F, Sciacca E et al. (2022). POS0145 CLINICAL RESPONSE TO RITUXIMAB IS ASSOCIATED WITH PREVENTION OF B-CELL DRIVEN SALIVARY GLAND INFLAMMATION AND EPITHELIAL RESTORATION AS REVEALED BY MOLECULAR PATHOLOGY: RESULTS FROM THE TRACTISS TRIAL IN PRIMARY SJOGREN’S SYNDROME. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.4458 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92607 Elshikh M, El Sayed R, Aly N et al. (2022). POS0431 PDGF-BB, TNF-α, AND LT-β REGULATE FOLLICULAR DENDRITIC CELL DEVELOPMENT IN THE RHEUMATOID SYNOVIUM. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.3358 QMRO: qmroHref Nerviani A, Boutet MA, Ghirardi GM et al. (2022). POS0441 IN-DEPTH ANALYSIS OF Axl AND MerTK EXPRESSION PATTERNS AND REGULATION BY BIOLOGIC TREATMENTS IN RHEUMATOID ARTHRITIS. nameOfConference DOI: 10.1136/annrheumdis-2022-eular.4486 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79779 Rivellese F, Surace AEA, Goldmann K et al. (2022). Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. nameOfConference DOI: 10.1038/s41591-022-01789-0 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78741 (publicationYear). RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients. nameOfConference DOI: 10.1038/s41597-022-01264-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78946 Banda NK, Deane KD, Seifert J et al. (2022). A Snap Shot of Complement Gene Expression and Presence of Complement Proteins in Synovial Biopsies from Early Rheumatoid Arthritis Patients. nameOfConference DOI: 10.4049/jimmunol.208.supp.108.03 QMRO: qmroHref Carlucci PM, Li J, Fava A et al. (2022). High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. nameOfConference DOI: 10.1093/rheumatology/keac067 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77492 Kefas J, Harwood C, Lewis MJ et al. (2022). Small vessel vasculitis and dry gangrene secondary to combined CTLA-4 and PD-1 blockade in malignant mesothelioma. nameOfConference DOI: 10.1186/s41927-021-00238-8 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78591 Micheroli R, Elhai M, Edalat S et al. (2022). Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis. nameOfConference DOI: 10.1136/rmdopen-2021-001949 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77959 Iakovliev A, Ling SF, Colombo M et al. (2022). Association of Genetic Loci for Human Plasma Proteins with Response to Treatment in People with Rheumatoid Arthritis. nameOfConference DOI: doi QMRO: qmroHref Banda N, Deane K, Seifert J et al. (2022). Complement gene expression and biodistribution of complement proteins in the synovium from early rheumatoid arthritis patients. nameOfConference DOI: doi QMRO: qmroHref Maurits M, Abasolo Alcazar L, van den Akker E et al. (2022). GWAS Identified New Genes in Synovial Fibroblasts Linked to Early Remission in RA. nameOfConference DOI: doi QMRO: qmroHref Rivellese F, Pontarini E, Cubuk C et al. (2022). Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88925 Prediletto E, Cubuk C, Pontarini E et al. (2022). Rheumatoid Synovial Fibroblasts Display Imprinted Memory of Their Synovial Endotype Which Can Be Plastically Modulated by B-cells Crosstalk. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83754 Pontarini E, Chowdhury F, Sciacca E et al. (2021). OP0136 RITUXIMAB PREVENTS THE PROGRESSION OF B-CELL DRIVEN INFLAMMATORY INFILTRATE IN THE MINOR SALIVARY GLANDS OF PRIMARY SJOGREN’S SYNDROME BY DOWNREGULATING IMMUNOLOGICAL PATHWAYS KEY IN ECTOPIC GERMINAL CENTRE ORGANIZATION: RESULTS FROM THE TRACTISS TRIAL. nameOfConference DOI: 10.1136/annrheumdis-2021-eular.3960 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/73039 Pontarini E, Sciacca E, Grigoriadou S et al. (publicationYear). NKp30 Receptor Upregulation in Salivary Glands of Sjögren’s Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment. nameOfConference DOI: 10.3389/fimmu.2021.706737 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74629 Deonaraine KK, Carlucci PM, Fava A et al. (2021). Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network. nameOfConference DOI: 10.1136/lupus-2021-000522 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77495 Boutet M-A, Nerviani A, Lliso-Ribera G et al. (publicationYear). Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response. nameOfConference DOI: 10.3389/fimmu.2021.686795 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77488 Colombo F, Corsiero E, Lewis MJ et al. (publicationYear). Generation of restriction endonucleases barcode map to trace SARS-CoV-2 origin and evolution. nameOfConference DOI: 10.1038/s41598-021-91264-6 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/72991 Rivellese F, Pontarini E, Fossati-Jimack L et al. (2021). OP0011 INTEGRATION OF FLOW AND DIGITAL CYTOMETRY IN EARLY TREATMENT-NAÏVE RHEUMATOID ARTHRITIS IDENTIFIES DISTINCT IMMUNOPHENOTYPES IN PERIPHERAL BLOOD AND DISEASE TISSUE. nameOfConference DOI: 10.1136/annrheumdis-2021-eular.438 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77498 Meednu N, Rangel-Moreno J, Zhang F et al. (publicationYear). Single cell analysis of RA synovial B cells reveals a dynamic spectrum of ectopic lymphoid B cell activation and hypermutation characterized by NR4A nuclear receptor expression. nameOfConference DOI: 10.1101/2021.05.14.443150 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79768 Manou-Stathopoulou S, Hann W, Pakozdi A et al. (2021). P162 Incidence of neutropaenia and infections in lupus patients on immunosuppression. nameOfConference DOI: 10.1093/rheumatology/keab247.158 QMRO: qmroHref Rivellese F, Manou-Stathopoulou S, Mauro D et al. (2021). Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus. nameOfConference DOI: 10.1136/lupus-2020-000445 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77489 Pitzalis C, Humby F, Rivellese F et al. (2021). Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes Article (Randomised Controlled Trial). nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69717 Boutet MA, Nerviani A, Ribera GL et al. (2021). Pentraxin-3 (PTX3) circulating and synovial expression levels correlate with rheumatoid arthritis severity and tissue infiltration independently of the response to conventional treatments. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77496 Pontarini E, Chowdhury F, Sciacca E et al. (2021). Rituximab Prevents the Progression of B-cell Driven Inflammatory Infiltrate in the Minor Salivary Glands of Primary Sjogren's Syndrome by Downregulating Immunological Pathways Key in Ectopic Germinal Centre Organization: Results from the TRACTISS Trial. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77494 Humby F, Durez P, Buch MH et al. (2021). Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. nameOfConference DOI: 10.1016/s0140-6736(20)32341-2 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70235 Nerviani A, Boutet M-A, Tan WSG et al. (2020). IL-23 skin and joint profiling in Psoriatic Arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors. nameOfConference DOI: 10.1136/annrheumdis-2020-218186 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68358 Sciacca E, Surace A, Lewis M et al. (2020). Novel Network Tool Highlights Key Features Associated with Disease Pathotypes and Response to Treatment in Early Rheumatoid Arthritis. ACR Convergence 2020 DOI: 10.1002/art.41538 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70169 Gomez EA, Colas RA, Souza PR et al. (publicationYear). Blood pro-resolving mediators are linked with synovial pathology and are predictive of DMARD responsiveness in rheumatoid arthritis. nameOfConference DOI: 10.1038/s41467-020-19176-z QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69225 Cherlin S, Lewis MJ, Plant D et al. (2020). Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response. nameOfConference DOI: 10.1136/annrheumdis-2020-217204 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66355 Alivernini S, MacDonald L, Elmesmari A et al. (2020). Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. nameOfConference DOI: 10.1038/s41591-020-0939-8 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66500 Bellan M, Quaglia M, Nerviani A et al. (2021). Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis.. nameOfConference DOI: 10.55563/clinexprheumatol/xyylza QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68045 Rivellese F, Humby F, Lliso Ribera G et al. (2020). OP0217 INVOLVEMENT OF LARGE JOINTS AT DISEASE PRESENTATION IS ASSOCIATED WITH DIVERSE HISTOPATHOLOGICAL FEATURES AND CLINICAL OUTCOMES IN EARLY RHEUMATOID ARTHRITIS. nameOfConference DOI: 10.1136/annrheumdis-2020-eular.2475 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71058 Nerviani A, Boutet MA, Ghirardi GM et al. (2020). THU0082 MERTK SYNOVIAL EXPRESSION CORRELATES WITH TREATMENT RESPONSE IN RHEUMATOID ARTHRITIS. nameOfConference DOI: 10.1136/annrheumdis-2020-eular.4207 QMRO: qmroHref Nerviani A, Di Cicco M, Mahto A et al. (publicationYear). A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients. nameOfConference DOI: 10.3389/fimmu.2020.00845 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65198 Bahal S, Pyne D, Rajakariar R et al. (2020). EP34 Assessing the ability of anti-C1q antibody measurement to predict a flare of lupus nephritis. nameOfConference DOI: 10.1093/rheumatology/keaa109.033 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66589 Humby FC, Lewis M, Durez P et al. (2020). O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF inhibitor therapy. nameOfConference DOI: 10.1093/rheumatology/keaa110.006 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68070 Nerviani A, Lliso-Ribera G, Boutet M-A et al. (2020). O20 Histological and molecular features of the diseased synovium in early untreated PsA in comparison with RA. nameOfConference DOI: 10.1093/rheumatology/keaa110.019 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68071 Rivellese F, Humby F, Bugatti S et al. (2020). P233 B cell-rich synovitis in early and established rheumatoid arthritis. nameOfConference DOI: 10.1093/rheumatology/keaa111.227 QMRO: qmroHref Sciacca E, Alaimo S, Pulvirenti A et al. (2020). P22 Micro-RNA enriched pathway impact analysis applied to synovial RNA-seq in early rheumatoid arthritis identifies response prediction pathways. British Society for Rheumatology Annual Conference 2020 DOI: 10.1093/rheumatology/keaa111.021 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69283 Bahal S, Pyne D, Rajakariar R et al. (2020). P13 Assessing the ability of Anti-C1q antibody measurement to predict a flare of lupus nephritis. Poster presentations DOI: 10.1136/lupus-2020-eurolupus.62 QMRO: qmroHref Rivellese F, Humby F, Bugatti S et al. (publicationYear). B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure.. nameOfConference DOI: 10.1002/art.41184 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63258 John CR, Watson D, Russ D et al. (2020). M3C: Monte Carlo reference-based consensus clustering. nameOfConference DOI: 10.1038/s41598-020-58766-1 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63004 Pagani S, Bellan M, Mauro D et al. (2020). New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis. nameOfConference DOI: 10.1155/2020/1614627 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62984 Rivellese F, Humby F, Bugatti S et al. (2020). B CELL-RICH SYNOVITIS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68913 Nerviani A, Lliso-Ribera G, Boutet M-A et al. (2020). HISTOLOGICAL AND MOLECULAR FEATURES OF THE DISEASED SYNOVIUM IN EARLY UNTREATED PSA IN COMPARISON WITH RA. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65697 Rivellese F, Humby F, Giorli G et al. (2020). Histo-pathological Cellular Markers of Treatment Response to Rituximab and Tocilizumab in Matched Pre- and Post-treatment Synovial Biopsies from the R4RA Randomised Clinical Trial in Rheumatoid Arthritis. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70852 Nerviani A, Boutet M-A, Ghirardi GM et al. (2020). MerTK Synovial Expression Correlates with Disease Activity and Treatment Response in Rheumatoid Arthritis Patients. nameOfConference DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/70851 Humby FC, Lewis M, Durez P et al. (2020). RANDOMISED, OPEN LABELLED CLINICAL TRIAL TO INVESTIGATE SYNOVIAL MECHANISMS DETERMINING RESPONSE: RESISTANCE TO RITUXIMAB VERSUS TOCILIZUMAB IN RA PATIENTS FAILING TNF INHIBITOR THERAPY. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66599 Pucino V, Certo M, Bulusu V et al. (2019). Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring. nameOfConference DOI: 10.1016/j.cmet.2019.10.004 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/61253 Lliso-Ribera G, Humby F, Lewis M et al. (2019). Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC). nameOfConference DOI: 10.1136/annrheumdis-2019-215751 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63523 John CR, Watson D, Barnes MR et al. (2020). Spectrum: fast density-aware spectral clustering for single and multi-omic data. nameOfConference DOI: 10.1093/bioinformatics/btz704 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/64588 Boutet M-A, Nerviani A, Lliso-Ribera G et al. (2019). Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.. nameOfConference DOI: 10.1093/rheumatology/kez358 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62220 Lewis MJ, Barnes MR, Blighe K et al. (2019). Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes. nameOfConference DOI: 10.1016/j.celrep.2019.07.091 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/59563 Humby F, Lewis M, Townsend MJ et al. (2020). Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Buch et al. nameOfConference DOI: 10.1136/annrheumdis-2019-215903 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/59783 El Shikh MEM, El Sayed R, Nerviani A et al. (2019). Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.. nameOfConference DOI: 10.1016/j.jaut.2019.06.008 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/58983 Rivellese F, Humby F, Bugatti S et al. (2019). THU0058 B CELL SYNOVITIS AND CLINICAL PHENOTYPES IN RHEUMATOID ARTHRITIS AT DIFFERENT DISEASE STAGES. Annual European Congress of Rheumatology, EULAR 2019 DOI: 10.1136/annrheumdis-2019-eular.1284 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68914 Manou-Stathopoulou S, Rivellese F, Mauro D et al. (2019). AB0179 THE TRANSCRIPTION FACTORS IKZF1 AND IKZF3 CONTROL B CELL ACTIVATION AND DIFFERENTIATION IN SYSTEMIC LUPUS ERYTHEMATOSUS. Abstracts Accepted for Publication DOI: 10.1136/annrheumdis-2019-eular.6343 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66221 Nerviani A, Ribera GL, Boutet MA et al. (2019). OP0113 HISTOLOGICAL AND MOLECULAR PORTRAIT OF THE SYNOVIAL TISSUE IN EARLY TREATMENT-NAÏVE PSORIATIC ARTHRITIS IN COMPARISON WITH RHEUMATOID ARTHRITIS. Oral Presentations DOI: 10.1136/annrheumdis-2019-eular.3634 QMRO: qmroHref Ribera GL, Humby F, Nerviani A et al. (2019). OP0120 BASELINE CELLULAR AND MOLECULAR CHARACTERISTICS OF SYNOVIAL TISSUE AND RELATION WITH TNFI RESPONSE. RESULTS FROM THE PATHOBIOLOGY OF THE EARLY ARTHRITIS COHORT (PEAC). Oral Presentations DOI: 10.1136/annrheumdis-2019-eular.2617 QMRO: qmroHref Mauro D, Rivellese F, Manou-Stathopoulou S et al. (2019). SAT0025 THE EFFECT OF DIMETHYL FUMARATE ON PLASMABLAST DIFFERENTIATION TRANSCRIPTIONAL PROGRAMMES IN SYSTEMIC LUPUS ERYTHEMATOSUS. SATURDAY, 15 JUNE 2019 DOI: 10.1136/annrheumdis-2019-eular.7792 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66175 Rivellese F, Manou-Stathopoulou S, Mauro D et al. (2019). THU0234 THE TRANSCRIPTION FACTORS IKAROS (IKZF1) AND AIOLOS (IKZF3) ARE EXPRESSED IN THE SALIVARY GLANDS OF SJÖGREN’S SYNDROME PATIENTS WITH LYMPHOID AGGREGATES AND MODULATE B CELL ACTIVATION IN VITRO. Poster Presentations DOI: 10.1136/annrheumdis-2019-eular.7333 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66219 John CR, Watson D, Barnes M et al. (publicationYear). Spectrum: Fast density-aware spectral clustering for single and multi-omic data. nameOfConference DOI: 10.1101/636639 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65942 Khan A, Pakozdi A, Rajakariar R et al. (2019). E090 Sleep disturbances in lupus patients. nameOfConference DOI: 10.1093/rheumatology/kez110.088 QMRO: qmroHref Almathkouri A, Pyne D, Rajakariar R et al. (2019). E091 Prevalence of fibromyalgia in a cohort of renal and non-renal systemic lupus erythematosus patients. nameOfConference DOI: 10.1093/rheumatology/kez110.089 QMRO: qmroHref Manou-Stathopoulou S, Rivellese F, Mauro D et al. (2019). 235 IKZF1 and IKZF3 inhibition impairs B cell differentiation and modulates gene expression in systemic lupus erythematosus. Abstracts DOI: 10.1136/lupus-2019-lsm.235 QMRO: qmroHref Twohig JP, Cardus Figueras A, Andrews R et al. (2019). Activation of naïve CD4+ T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4+ T cells. nameOfConference DOI: 10.1038/s41590-019-0350-0 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/59555 Humby F, Lewis M, Ramamoorthi N et al. (2019). Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.. nameOfConference DOI: 10.1136/annrheumdis-2018-214539 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/58941 Boutet M-A, Nerviani A, Lliso-Ribera G et al. (2019). P125 IL-36 axis is an emerging therapeutic target in psoriatic arthritis synovial tissue. Abstracts DOI: 10.1136/annrheumdis-2018-ewrr2019.113 QMRO: qmroHref Hensor EMA, McKeigue P, Ling SF et al. (2019). Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.. nameOfConference DOI: 10.1093/rheumatology/kez049 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/56623 Bottini A, Wu DJ, Ai R et al. (2019). PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes. nameOfConference DOI: 10.1136/annrheumdis-2018-213799 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/56182 Dorris ER, Tazzyman SJ, Moylett J et al. (2019). The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation. nameOfConference DOI: 10.4049/jimmunol.1801155 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/55324 Humby F, Buch MH, Durez P et al. (2019). A Randomised, Open Labelled Clinical Trial to Investigate Synovial Mechanisms Determining Response - Resistance to Rituximab versus Tocilizumab in Rheumatoid Arthritis Patients Failing TNF Inhibitor Therapy. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65449 Antbring R, Cunningham M, Bull R et al. (2019). Lupus Teledematology: A Pilot Project to Evaluate the Plausibility of a Rapid Access Dermatology Service for Lupus Patients. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66384 Almathkouri A, Pyne D, Rajakariar R et al. (2019). PREVALENCE OF FIBROMYALGIA IN A COHORT OF RENAL AND NON-RENAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65885 Khan A, Pakozdi A, Rajakariar R et al. (2019). SLEEP DISTURBANCES IN LUPUS PATIENTS. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65933 Nerviani A, Mauro D, Gilio M et al. (2018). To supplement or not to supplement? The rationale of vitamin D supplementation in systemic lupus erythematosus. nameOfConference DOI: 10.2174/1874312901812010226 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/57680 Cope AP, Barnes MR, Belson A et al. (2018). The RA-MAP Consortium: a working model for academia-industry collaboration.. nameOfConference DOI: 10.1038/nrrheum.2017.200 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/35063 Consortium R-M (2018). Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. nameOfConference DOI: 10.1136/rmdopen-2018-000721 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63758 Khan A, Lewis M, Thomas G (2018). 46. Subglottic stenosis in a patient with granulomatosis with polyangiitis recently treated with rituximab. nameOfConference DOI: 10.1093/rap/rky034.009 QMRO: qmroHref John C, Watson D, Russ D et al. (2018). M3C: Monte Carlo reference-based consensus clustering. nameOfConference DOI: 10.1101/377002 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/64683 Lewis MJ, Barnes MR (2018). RNA sequencing and machine learning as molecular scalpels.. nameOfConference DOI: 10.1038/s41584-018-0012-x QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/39553 Almathkouri A, Pyne D, Pakozdi A et al. (2018). AB0545 Is lupus more prevalent in world’s most stressed countries?. nameOfConference DOI: 10.1136/annrheumdis-2018-eular.1476 QMRO: qmroHref Mauro D, Tsang V, Lucey-Clayton I et al. (2018). FRI0271 Dimethyl fumarate inhibits ube2l3 mediated tlr7 signalling and autoreactive b cell development in sle. FRIDAY, 15 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.6960 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66741 Lliso-Ribera G, Humby F, Nerviani A et al. (2018). OP0040 Synovial cell infiltration in acpa-ve patients displays similar signatures to other seronegative inflammatory arthritis. results from the pathobiology of early arthritis cohort (PEAC). WEDNESDAY, 13 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.3489 QMRO: qmroHref Boutet M-A, Nerviani A, Lliso-Ribera G et al. (2018). SAT0024 Il-36 axis is an emerging therapeutic target in psoriatic arthritis synovial tissue. Saturday, 16 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.3485 QMRO: qmroHref Nerviani A, Mauro D, Pagani S et al. (2018). THU0061 Restricted axl synovial expression and increased cleavage of axl ectodomain correlate with highly inflamed synovitis and more severe rheumatoid arthritis. THURSDAY, 14 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.6988 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65908 Rivellese F, Congia M, Mauro D et al. (2018). THU0070 The transcription factors ikaros and aiolos are expressed in the synovial membrane of early rheumatoid arthritis patients in association with synovial lymphoid aggregates. THURSDAY, 14 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.6442 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66220 Purkayastha N, Tan WS, Mahto A et al. (2018). THU0122 Imaging characterisation of remission in rheumatoid arthritis. THURSDAY, 14 JUNE 2018 DOI: 10.1136/annrheumdis-2018-eular.1264 QMRO: qmroHref Waller A, Goulden B, Pakozdi A et al. (2018). 125 Self reported alopecia in an ethnically diverse lupus cohort. nameOfConference DOI: 10.1093/rheumatology/key075.349 QMRO: qmroHref Wheeler LM, Pakozdi A, Rajakariar R et al. (2018). 139 Moving with the times: social media use amongst lupus patients. nameOfConference DOI: 10.1093/rheumatology/key075.363 QMRO: qmroHref Ribera GL, Humby F, Kelly S et al. (2018). 244 The clinical phenotype of inflammatory arthritis correlates with synovial immune cell infiltration: results from the pathobiology of early arthritis cohort. nameOfConference DOI: 10.1093/rheumatology/key075.468 QMRO: qmroHref Ribera GL, Humby F, Kelly S et al. (2018). O09 A lymphoid pathotype at baseline, in early inflammatory arthritis, significantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort. nameOfConference DOI: 10.1093/rheumatology/key075.191 QMRO: qmroHref Hensor EMA, McKeigue P, Buch MH et al. (2018). O12 Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis. nameOfConference DOI: 10.1093/rheumatology/key075.194 QMRO: qmroHref Lewis MJ, McAndrew MB, Wheeler C et al. (2018). Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus. nameOfConference DOI: 10.1016/j.jaut.2018.02.009 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/39555 Almathkouri A, Pyne D, Pakozdi A et al. (2018). PS2:43 Is lupus more prevalent in world’s most stressed countries?. Poster session 2: Autoantibodies, biomarkers and imaging (2), Environmental, epigenetics and genomics DOI: 10.1136/lupus-2018-abstract.91 QMRO: qmroHref Wheeler L, Pakozdi A, Rajakariar R et al. (2018). PS8:159 Moving with the times: social media use amongst lupus patients. Poster session 8: Registries and cohorts DOI: 10.1136/lupus-2018-abstract.202 QMRO: qmroHref Cope AP, Barnes MR, Belson A et al. (2018). Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. nameOfConference DOI: 10.1038/nrrheum.2018.6 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65530 Ribera GL, Humby F, Kelly S et al. (2018). A LYMPHOID PATHOTYPE AT BASELINE, IN EARLY INFLAMMATORY ARTHRITIS, SIGNIFICANTLY ASSOCIATES WITH REQUIREMENT FOR BIOLOGIC THERAPY AT 12 MONTHS FOLLOW UP: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT. nameOfConference DOI: doi QMRO: qmroHref Nerviani A, Humby F, Ribera GL et al. (2018). Comparative Histologic and Molecular Analysis of Synovial Tissue in Early Treatment-Naive Psoriatic and Rheumatoid Arthritis. nameOfConference DOI: doi QMRO: qmroHref Rivellese F, Mauro D, Congia M et al. (2018). Expression and Functions of the Transcription Factors Ikaros and Aiolos in Sjogren's Syndrome and Systemic Lupus Erythematosus. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65646 Wheeler LM, Pakozdi A, Rajakariar R et al. (2018). MOVING WITH THE TIMES: SOCIAL MEDIA USE AMONGST LUPUS PATIENTS. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65747 Bottini A, Wu DJ, Ai R et al. (2018). Non-Receptor Protein Tyrosine Phosphatase 14 (PTPN14) Promotes YAP-Dependent Tgfbeta Signaling in RA FLS. nameOfConference DOI: doi QMRO: qmroHref Waller A, Goulden B, Pakozdi A et al. (2018). SELF REPORTED ALOPECIA IN AN ETHNICALLY DIVERSE LUPUS COHORT. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65928 Ribera GL, Humby F, Kelly S et al. (2018). THE CLINICAL PHENOTYPE OF INFLAMMATORY ARTHRITIS CORRELATES WITH SYNOVIAL IMMUNE CELL INFILTRATION: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT. nameOfConference DOI: doi QMRO: qmroHref Pullabhatla V, Roberts AL, Lewis MJ et al. (2018). De novo mutations implicate novel genes in systemic lupus erythematosus. nameOfConference DOI: 10.1093/hmg/ddx407 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/32326 Ursini F, Leporini C, Bene F et al. (publicationYear). Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. nameOfConference DOI: 10.1038/s41598-017-05759-2 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/25225 Lliso-Ribera G, Humby F, Kelly S et al. (2017). FRI0088 Synovial pathobiology correlates with diagnostic subgroups in early inflammatory arthritis: results from the pathobiology of early arthritis cohort (PEAC). Poster Presentations DOI: 10.1136/annrheumdis-2017-eular.2927 QMRO: qmroHref Lliso-Ribera G, Humby F, Kelly S et al. (2017). THU0100 In early inflammatory arthritis a lymphoid pathotype signficantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort (PEAC). Poster Presentations DOI: 10.1136/annrheumdis-2017-eular.6042 QMRO: qmroHref Bombardieri M, Lewis M, Pitzalis C (publicationYear). Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. nameOfConference DOI: 10.1038/nrrheum.2016.217 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/19652 Bahal S, Pyne D, Rajakariar R et al. (2017). Anti-C1q Antibodies and Disease Activity in a Multi-Ethnic Lupus Cohort. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65463 Mauro D, Tsang V, Clayton-Lucey IA et al. (2017). Regulation of TLR7 Signalling By UBE2L3 Dependent Linear Ubiquitination Explains Dimethyl Fumarate Suppression of Autoreactive B Cell Development in SLE. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65899 Etomi O, Cove-Smith A, Rajakariar R et al. (2017). The Prevalence of Autoimmune Disease in Families of Patients with Systemic Lupus Erythematosus (SLE). a Single Centre Study. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66215 Nerviani A, Pagani S, Mauro D et al. (2017). Tyrosine Kinase Receptor Axl Is Down Regulated in Highly Inflamed Rheumatoid Synovium and Negatively Correlates with Markers of Disease Activity. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66227 Lewis MJ, Jawad AS (publicationYear). The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. nameOfConference DOI: 10.1093/rheumatology/kew399 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/19700 Nerviani A, DiCicco M, Humby F et al. (2016). FRI0157 A Baseline Prediction Model for Response To Certolizumab-Pegol: Role of Synovial Histopathology. nameOfConference DOI: 10.1136/annrheumdis-2016-eular.4218 QMRO: qmroHref Mauro D, Lewis MJ, Pullabhatla V et al. (2016). OP0232 C1qtnf4 Mutation Identified by Exome Sequencing Is Associated with Systemic Lupus Erythematosus and Dysregulation of Tnf-Induced Apoptosis. nameOfConference DOI: 10.1136/annrheumdis-2016-eular.5597 QMRO: qmroHref Mahto A, Humby F, Gregoriadou S et al. (2016). OP0263 Synovial B-Cell Gene Signature Predicts Response To Rituximab Therapy. nameOfConference DOI: 10.1136/annrheumdis-2016-eular.5428 QMRO: qmroHref Mauro D, Lewis MJ, Pullabhatla V et al. (2016). C1QTNF4 MUTATION IDENTIFIED BY EXOME SEQUENCING IS ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND DYSREGULATION OF TNF-INDUCED APOPTOSIS. Annual European Congress of Rheumatology EULAR 2016 DOI: 10.1136/annrheumdis-2016-eular.4039 QMRO: qmroHref Lewis MJ, McAndrew MB, Wheeler C et al. (2016). FUNCTIONAL CLUSTERS OF AUTOANTIBODIES TARGETING TLR AND SMAD PATHWAYS DEFINE NEW SUBGROUPS IN SYSTEMIC LUPUS ERYTHEMATOSUS. Annual European Congress of Rheumatology EULAR 2016 DOI: 10.1136/annrheumdis-2016-eular.6111 QMRO: qmroHref Nerviani A, DiCicco M, Kelly S et al. (2016). FIBROID SYNOVIAL PATHOTYPE AND TYROSINE KINASE AXL CORRELATE WITH POOR CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PATIENTS. Rheumatology 2016 DOI: 10.1093/rheumatology/kew121.004 QMRO: qmroHref Lewis MJ, Vyse S, Shields AM et al. (2016). 205 Correlation of Soluble Vascular Cell Adhesion Molecule 1 with B Cell Activation and Plasma Cells in Systemic Lupus Erythematosus. nameOfConference DOI: 10.1093/rheumatology/kew173.002 QMRO: qmroHref Lewis MJ, Vyse S, Shields AM et al. (2016). CORRELATION OF SOLUBLE VASCULAR CELL ADHESION MOLECULE 1 WITH B CELL ACTIVATION AND PLASMA CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS. British Society for Rheumatology annual conference 2016 DOI: doi QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62506 Lewis MJ, Vyse S, Shields AM et al. (2016). Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1. nameOfConference DOI: 10.1186/s13075-015-0896-7 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/10951 Hensor EMA, McKeigue P, Conaghan PG et al. (2016). Validity of a 2-Component Disease Activity Score for Accurate Assessment of Synovitis in Rheumatoid Arthritis. nameOfConference DOI: doi QMRO: qmroHref Shields AM, Vyse S, Walczak H et al. (2015). O37. The Autoimmune Risk Gene UBE2L3 is Highly Expressed During B Cell Proliferation and is Correlated with Plasmablast and Plasma Cell Expansion in SLE. nameOfConference DOI: 10.1093/rheumatology/kev085.001 QMRO: qmroHref Vyse S, Shields A, Boeltz S et al. (2015). A2.10 SLE associated UBE2L3 haplotype modulates plasma cell differentiation via genotypic regulation of NF-κB. nameOfConference DOI: 10.1136/annrheumdis-2015-207259.45 QMRO: qmroHref Lewis M, Vyse S, Shields A et al. (2015). Effect of UBE2L3 genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus. nameOfConference DOI: 10.1016/s0140-6736(15)60324-5 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/19703 Lewis MJ, Vyse S, Shields AM et al. (2015). UBE2L3 Polymorphism Amplifies NF-κB Activation and Promotes Plasma Cell Development, Linking Linear Ubiquitination to Multiple Autoimmune Diseases. nameOfConference DOI: 10.1016/j.ajhg.2014.12.024 QMRO: qmroHref Shields AM, Vyse S, Walczak H et al. (2015). THE AUTOIMMUNE RISK GENE UBE2L3 IS HIGHLY EXPRESSED DURING B CELL PROLIFERATION AND IS CORRELATED WITH PLASMABLAST AND PLASMA CELL EXPANSION IN SLE. nameOfConference DOI: doi QMRO: qmroHref Lewis MJ, Vyse S, Boeltz S et al. (2014). O47. SLE Susceptibility Gene UBE2L3 Polymorphism Controls Sensitivity of NF-KB to TNF and CD40 In Vivo. nameOfConference DOI: 10.1093/rheumatology/keu093.005 QMRO: qmroHref McAndrew M, Wheeler C, Koopmann J et al. (2013). SAT0528 Novel Autoantibody Biomarkers for the Improved Diagnosis of Systemic Lupus Erythematosus. nameOfConference DOI: 10.1136/annrheumdis-2013-eular.2252 QMRO: qmroHref Lewis MJ, Vyse S, Shields AM et al. (2014). UBE2L3 genotype Influences Plasma Cell Proliferation in Systemic Lupus Erythematosus By Regulation of NF-κB By the Linear Ubiquitination Assembly Complex.. nameOfConference DOI: doi QMRO: qmroHref Lewis MJ, Vyse S, Boeltz S et al. (2014). SLE SUSCEPTIBILITY GENE UBE2L3 POLYMORPHISM CONTROLS SENSITIVITY OF NF-KB TO TNF AND CD40 IN VIVO. nameOfConference DOI: doi QMRO: qmroHref Davies R, Sangle S, Jordan N et al. (2013). Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. nameOfConference DOI: 10.1177/0961203313483376 QMRO: qmroHref Lewis MJ, Malik TH, Fossati‐Jimack L et al. (2012). Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia. nameOfConference DOI: 10.1002/art.34451 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/19701 Haskard D, Talat M, Lewis M et al. (2011). Bifunctional roles of complement and antibodies in atherosclerosis. nameOfConference DOI: doi QMRO: qmroHref Malik TH, Cortini A, Carassiti D et al. (2010). FC4 The alternative pathway is critical for pathogenic complement activation in diet -induced and endotoxin-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. nameOfConference DOI: 10.1136/hrt.2010.205781.10 QMRO: qmroHref Lewis MJ, Malik TH, Ehrenstein MR et al. (2009). Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice. nameOfConference DOI: 10.1161/circulationaha.109.868158 QMRO: qmroHref Lewis MJ, Botto M (2006). Complement deficiencies in humans and animals: Links to autoimmunity. nameOfConference DOI: 10.1080/08916930600739233 QMRO: qmroHref Lewis MJ, Malik TH, Fossati-Jimack LM et al. (2009). COMPLEMENT DYSREGULATION LINKS ACCELERATED ATHEROSCLEROSIS AND GLOMERULONEPHRITIS IN SLE. nameOfConference DOI: doi QMRO: qmroHref Lewis MJ, Malik TH, Ehrenstein MR et al. (2008). Hierarchical contributions of IgM and complement C1q in protection against murine atherosclerosis. nameOfConference DOI: 10.1096/fasebj.22.1_supplement.463.2 QMRO: qmroHref Lewis MJ, Malik TH, Ehrenstein MR et al. (2008). Atheroprotective functions of IgM and complement C1q: do low IgM levels and impaired complement activity provide a new link between atherosclerosis and SLE?. nameOfConference DOI: doi QMRO: qmroHref Lewis MJ, Malik TH, Ehrenstein MR et al. (2008). IgM deficiency accelerates atherosclerosis: A potential adverse consequence of B cell depletion therapy?. nameOfConference DOI: doi QMRO: qmroHref Lewis MJ, Malik TH, Fossati-Jimack LM et al. (2008). Lupus phenotype accelerates atherosclerosis in a novel mouse model of SLE. nameOfConference DOI: doi QMRO: qmroHref Lewis MJ, Malik TH, Ehrenstein MR et al. (2007). Serum IgM plays an important protective role in murine atherosclerosis. nameOfConference DOI: 10.1016/j.atherosclerosis.2007.04.015 QMRO: qmroHref Kenwright S, Maughan T, Lewis M (2005). The Assisted Dying for the Terminally Ill Bill 2004. nameOfConference DOI: 10.7861/clinmedicine.5-2-185 QMRO: qmroHref Lewis M, D'cruz D (2005). Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus. nameOfConference DOI: 10.1177/096120330501400105 QMRO: qmroHref Lewis M (2005). The Assisted Dying for the Terminally Ill Bill 2004.. nameOfConference DOI: 10.7861/clinmedicine.5-2-185 QMRO: qmroHref Descamps MJL, Lewis MJ, Hart PE et al. (2004). Brainstem Infarction during Long-Haul Air Travel. nameOfConference DOI: 10.1159/000081862 QMRO: qmroHref Lewis MJ, Greenwood RJ, Brew S et al. (2003). Economy class stroke syndromes: vertebral artery dissection revisited. nameOfConference DOI: 10.1136/jnnp.74.11.1594 QMRO: qmroHref Lewis M, Gibson T (2003). Systemic lupus erythematous with recurrent Guillain -Barré-like syndrome treated with intravenous immunoglobulins. nameOfConference DOI: 10.1191/0961203303lu464cr QMRO: qmroHref Lewis MJ, Chan YP, Lewis RR (2002). Ring Lesions in the Brain and A Mass in the Kidney. nameOfConference DOI: 10.1177/014107680209500110 QMRO: qmroHref Lewis MJ, Chan YP, Lewis RR (2002). Ring lesions in the brain and a mass in the kidney.. nameOfConference DOI: 10.1177/014107680209500110 QMRO: qmroHref Sponsors National Institute for Health and Care Research Medical Research Council Versus Arthritis Barts Charity British Sjögren's Syndrome Association FOREUM Foundation for Research in Rheumatology CollaboratorsInternal Prof Costantino Pitzalis Prof Michele Bombardieri Prof Francesco Dell’Accio Prof Shafaq Sikandar Prof Michael Barnes Dr Paul Pfeffer Prof Jesmond Dalli Dr Adam Brentnall Prof Marta Korbonits Prof Pedro Cutillas Dr James Whiteford External Prof Anne Barton (Manchester) Prof Paul McKeigue (Edinburgh) Prof Heather Cordell (Newcastle) Prof Iain McInnes (Glasgow) Prof Simon Jones (Cardiff) Prof Tim Vyse (KCL) Prof Francesca Capon (KCL) Prof James Wason (Newcastle) Dr Rachael Bashford-Rogers (Oxford) Industry GSK Celgene DisclosuresProf Lewis is a co-inventor on three patents which have been licensed to Exagen Inc, USA: US20200399703 – Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (RA) (Genentech, QMUL – Pitzalis, Lewis, Townsend, Ramamoorthi, Hackney) WO/2021/064371 / Application no. GB 1914079.7 – Method of predicting requirement of biologic therapy (QMUL – Pitzalis, Lewis, Humby) WO/2022/157506 / Application no. GB 2100821.4 – Method for treating rheumatoid arthritis (QMUL – Pitzalis, Lewis) Back to top